Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MLXIPL | hg38_v1_chr7_-_73624492_73624549 | -0.45 | 1.0e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_142352802 Show fit | 7.35 |
ENST00000634605.1
|
T cell receptor beta variable 7-2 |
|
chr14_-_105644790 Show fit | 6.00 |
ENST00000641095.1
ENST00000390545.3 |
immunoglobulin heavy constant gamma 2 (G2m marker) |
|
chr14_-_106269133 Show fit | 4.90 |
ENST00000390609.3
|
immunoglobulin heavy variable 3-23 |
|
chr14_-_105771405 Show fit | 4.69 |
ENST00000641136.1
ENST00000390551.6 |
immunoglobulin heavy constant gamma 3 (G3m marker) |
|
chr14_-_105856183 Show fit | 4.17 |
ENST00000637539.2
ENST00000390559.6 |
immunoglobulin heavy constant mu |
|
chr21_-_44910630 Show fit | 3.74 |
ENST00000320216.10
ENST00000397852.5 |
integrin subunit beta 2 |
|
chr14_-_106301848 Show fit | 3.50 |
ENST00000390611.2
|
immunoglobulin heavy variable 2-26 |
|
chr8_+_11494367 Show fit | 3.46 |
ENST00000259089.9
ENST00000529894.1 |
BLK proto-oncogene, Src family tyrosine kinase |
|
chr14_-_105708627 Show fit | 3.40 |
ENST00000641837.1
ENST00000390547.3 |
immunoglobulin heavy constant alpha 1 |
|
chr22_+_22906342 Show fit | 3.30 |
ENST00000390325.2
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 60.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 27.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 17.4 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 15.5 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.1 | 14.1 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 9.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 8.9 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.2 | 8.3 | GO:0045730 | respiratory burst(GO:0045730) |
0.3 | 7.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 6.8 | GO:0007286 | spermatid development(GO:0007286) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 48.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 17.2 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 14.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 13.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.8 | 9.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.0 | 8.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.6 | 7.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.9 | 7.3 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.0 | 6.5 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 5.9 | GO:0035580 | specific granule lumen(GO:0035580) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 69.1 | GO:0003823 | antigen binding(GO:0003823) |
0.9 | 61.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 11.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.0 | 11.0 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.5 | 7.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 5.8 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
1.8 | 5.3 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.3 | 5.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 5.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 4.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 17.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 17.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 11.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 9.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 9.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 7.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 6.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 6.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 6.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 5.6 | PID PLK1 PATHWAY | PLK1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 20.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 14.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 8.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 8.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 6.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 6.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 5.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 5.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 4.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 4.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |